Artificial Cochlea Technological Innovation and Future Scope

Artificial cochlea or cochlear implant is an electronic device that transmit a sense of sound to person severely deaf. The implant consists of an external portion that sits behind the ear and a second portion that is surgically placed under the skin. A cochlear implant is very different from a hearing aid.

Hearing aids amplify sounds so they may be detected by damaged ears, whereas, cochlear implants bypass damaged portions of the ear and directly stimulate the auditory nerve. Signals generated by the implant are sent by way of the auditory nerve to the brain, which recognizes the signals as sound. Hearing through a cochlear implant is different from normal hearing and takes time to learn or relearn.

Download PDF Brochure Click Here!!


 Top Dominating Key Players:

  1. Boston Scientific Corporation
  2. Cochlear Ltd
  3. NeuroPace, Inc.
  4. Medtronic
  5. GN Store Nord
  6. MED-EL
  7. Sonova Holding AG
  8. Starkey Hearing Technologies
  9. Widex A/S
  10. RION Co. Ltd

Rising number of new cases of hearing loss in geriatric population, development of new technology in cochlea implants, favorable reimbursement policies are driving the Artificial Cochlea market. The government initiatives such as the Patient Protection and Affordable Care Act (ACA) has several provisions for improving the hearing ability are driving the Artificial Cochlea market.

The global Artificial Cochlea market is segmented on the type, end user. Based on type, the market is segmented into unilateral implantation, and bilateral implantation. Based on end user, the market is segmented into Children, and Adult.
  • Do you need actual market size estimates for the Artificial Cochlea market?
  • Do you want to know the most attractive market segments in the Artificial Cochlea market?
  • Do you need technological insights into the Artificial Cochlea market?
  • Do you wish to benchmark your position in the global Artificial Cochlea market?
  • Do you need concrete data for making actionable business strategies?

Source :The Insight Partners

Comments

Post a Comment

Popular posts from this blog

Immunochemistry Equipment Market to Reflect a Holistic Expansion During 2019 to 2027

Image
The growth of the market is driven by the factors such as, rising incidences of chronic and infectious diseases and increasing geriatric population. However, the market is likely to slower down its growth due to the limitations associated with immunohistochemistry. The countries in the region are creating significant opportunities for the key market players to expand their business. It is likely to be a major factor contributing to the market growth during the coming years. With rising costs of production against their practices, the healthcare companies are striving to produce sufficient revenue to entertain their investors. The markets in some growing economies are expected to be an essential part of offering more reliable and profitable growth opportunities for the major players to expand their industry and geographic scope. Register for a free Trial today and gain instant*access @ Click Here Key Players Influencing the Market: PerkinElmer, Inc. Abcam Plc Ag
Read more

Biopharmaceutical Contract Manufacturing Market to Witness an Outstanding Growth by 2027

Image
The growth of the market is driven by factors such as the increasing outsourcing by pharmaceutical companies and increasing demand of biologics in the European region. However, increasing competition in the industry is likely to restrain the market growth to a certain extent. Manufacturing of Biopharmaceutical medicines through contract manufacturer from DNA to finished final product. Contract manufacturing is the type of outsourcing where a company enters into an agreement or legal settlement with another manufacturing firm for products, parts, or components, which the former will then use in its production process to complete its product. Register for a free Trial today and gain instant*access @ Click Here Key Players Influencing the Market: Lonza Group AG Boehringer Ingelheim International GmbH Inno Biologics Ventures Sdn Bhd Thermo Fisher Scientific AbbVie Inc. WuXi Biologics General Electric Samsung Biologics Merck KGaA Ajinomoto Co., Inc
Read more

Patient Registry Software Market Set for Rapid Growth and Trend by 2027

Image
The factors contributing to the growth of the Patient Registry Software market in Growing expenditure of digital healthcare, rising number of patients enrolling in patient registries and others. In the past few years, the Patient Registry has become a significant field in the North America medical sector, experiencing good development vision for the treatment of some challenging diseases. The government of the country organized various awareness programs for utilization of the patient registry. Moreover, the growing number of players operating across the region for patient registry software. The countries such as US and Canada are estimated to serve various growth opportunities due to the rising development in the healthcare IT sector. Register for a free Trial today and gain instant*access @ Click Here Key Players Influencing the Market: ARMUS Corporation CEDARON Dacima Software Inc. Doorn Corporation Evado Clinical FIGmd Inc. Global Vision Technologies, Inc
Read more